Bill Ackman’s Pershing Square hedge fund made an inauspicious appearance on an HSBC weekly hedge fund list in a ratings and performance reporting issue out today. Pershing Square cracked the bottom 20 worst performing list – and answers or questions that were or were not asked during Valeant Pharma due diligence might be at fault.
Ackman down in performance as SIRF and Citron administer a one-two puch
Pershing Square has never finished a year at the bottom of the HSBC performance ranking. For the hedge fund activist that in 2014 finished 8th on the list of best...


